Neurogene Appoints Christy Shafer as Chief Commercial Officer
PUBLIC · NGNEApr 20, 2026
Position
Chief Commercial Officer
Company
Neurogene
Christy Shafer
New YorkOtherBiotechnologyHealth CareTherapeutics
Description
Neurogene announces the appointment of Christy Shafer as Chief Commercial Officer to lead its commercial strategy for the NGN-401 gene therapy. This hiring strengthens Neurogene's executive team as it prepares for significant growth in advancing its neurology-focused therapies.
Who to call at Neurogene, and when
A new leader at Neurogene brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Neurogene raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Neurogene, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neurogene. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Neurogene
Location
New York, New York, United States
About
Neurogene Inc. is a clinical-stage company dedicated to bringing life-changing genetic medicines to patients and families affected by rare neurological diseases. The company focuses on developing novel approaches and treatments to overcome the limitations of conventional gene therapy in central nervous system disorders.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neurogene changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
New YorkOtherBiotechnologyHealth CareTherapeutics